Inventor · Milford, NJ, US

Harry G. Brittain

27Patents
4h-index
10Co-inventors
60Inventor score

Filing activity: Sep 8, 1986 → Feb 24, 2021

Most-cited inventions

PatentTitleAreaCited byStatus
US4861727A Luminescent oxygen sensor based on a lanthanide complex Emerging Cross-Sectional Technologies 65 Expired
US5190729A Luminescent oxygen sensor based on a lanthanide complex Physics 27 Expired
US8173625B2 Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanine Chemistry; Metallurgy 16 Active
US8304404B2 Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanine Chemistry; Metallurgy 4 Active
US7279579B2 Polymorphic forms of naltrexone Chemistry; Metallurgy 2 Expired
US8975272B2 Polymorphic forms of naltrexone Chemistry; Metallurgy 2 Active
US10166228B2 Polymorphic forms of naltrexone Chemistry; Metallurgy 1 Active
US9289438B2 Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanine Chemistry; Metallurgy 1 Active
US9603937B2 Platform drug delivery system utilizing crystal engineering and theanine dissolution Emerging Cross-Sectional Technologies 1 Active
US8685948B2 Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanine Chemistry; Metallurgy 1 Active
US9289439B2 Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanine Chemistry; Metallurgy 1 Active
US9289440B2 Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanine Chemistry; Metallurgy 1 Active
US8476250B2 Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanine Chemistry; Metallurgy 1 Active
US9603939B2 Platform drug delivery system utilizing crystal engineering and theanine dissolution Emerging Cross-Sectional Technologies 1 Active
US9556189B2 Polymorphic forms of naltrexone Chemistry; Metallurgy 1 Active
US8389540B2 Polymorphic forms of naltrexone Chemistry; Metallurgy 1 Active
US9603938B2 Platform drug delivery system utilizing crystal engineering and theanine dissolution Emerging Cross-Sectional Technologies 1 Active
US8735420B2 Polymorphic forms of naltrexone Chemistry; Metallurgy 1 Active
US9365580B2 Polymorphic forms of naltrexone Chemistry; Metallurgy 0 Active
US9980958B2 Polymorphic forms of naltrexone Chemistry; Metallurgy 0 Active
US10548905B2 Amorphous onapristone compositions and methods of making the same Chemistry; Metallurgy 0 Active
US9827240B2 Polymorphic forms of naltrexone Chemistry; Metallurgy 0 Active
US10328070B1 Polymorphic forms of naltrexone Chemistry; Metallurgy 0 Active
US9221830B2 Polymorphic forms of naltrexone Chemistry; Metallurgy 0 Active
US10376464B2 Characterization of the cocrystal products formed by metoprolol and dabigatran bases with L-theanine Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.